Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just checked right now and yes we are!!!
Pink Current again..lol. Who sold yesterday?
OTC Markets doesn’t care about these penny stocks anymore. They are tolerating them at best now with hardly any set process for classification and disclosures. They made their choice with their own F stock ticker and ADR business.
It’s not even just that though. You’ve been doing this long before they were put on the expert market the first time. Just can’t imagine waking up everyday and saying you know “who I’m gonna get on the Internet and support today?” Grover and HMLA
Agreed Big Juan this is total bs , hope to load up some cheapies before everyone else when it back to pink current
Agreed looks like it was a simple error on behalf of the otc market, what bs that they expert market them without notice.
No it should have been limited with grace period. This instant move to EM is total bullshit and something everyone should call and bitch at otc markets about!
Current again Friday...The computer saw we never filed a Q go Jan and had not filed for April so it automatically put us in delinquent status. When guy looked at he realized that 10 we filed covered Jan and April would be first filing. We should not have been put in delinquent status. Fixed tom.
It wasn't the companies fault, the OTC markets fked up.You don't delist a company because they are a few days late on a 10Q...glty!
Lets hope its as simple as that
Don’t you get tired making excuses for why this has been a piece of shit for so long
It will be current a day after the 10Q is posted, its just ridiculous to give your shares away over a day or two wait.
$HMLA
.0012 - 65.7 % I have now placed a buy order at 0.0001
qoute : $HMLA ouch Target 0.0001 ? Expert Market
This is the BS with OTCmarkets after they bring them off EM……..
$HMLA April 30 10-Q has been completed and sent to auditor for consent to be filed in the next 24-48 hours; looking for MM to file form 211 for the stock; name change still pending FINRA review to HIMALAYA TECHNOLOGIES, INC., ticker to remain the same so procedural.
https://twitter.com/vikpgrover/status/1536059543582658561?s=21&t=Klegpi_mt9-gSE9dlteeNg
$HMLA ouch Target 0.0001 ? Expert Market
$HMLA ouch Target 0.0001 ?
— TB (@tb97132232) June 15, 2022
🚨 HMLA
💰 0,0036
☠️ Market Updated:
🔴Old Value: Pink Current
🟢New Value: Expert Market
Graph: https://t.co/iE3b86U61K
AS: 1.000.000.000
OS: 147.201.861
Updated: 2022-06-15 07:03:05
Find more on https://t.co/ADzCz57wIl
Nice...we are so ready to fly
Sprecher 8k is out, they need to PR it.
$HMLA
No changes for almost 2 months.
$HMLA SS updated 6/8/22
Outstanding Shares
147,201,861
06/08/2022
Restricted
18,705,430
06/08/2022
Unrestricted
128,496,431
06/08/2022
Held at DTC
111,850,839
06/08/2022
They better PR this, Sprecher brewing is the real deal.
$HMLA
Folks still selling into the bids, SS has been unchanged for over a month, nothing is on the offer, just need a catalyst.
$HMLA
Alright, hopefully both stocks will move again soon.
Because the otc is currently dead and if something gets decent dollar volume, it sure won’t be a fluff pump by Grover.
This is why no one cares. Grover has a rep
News was light, just as volume today. Most likely someone who who got shares in the .003s sold today.
This wasn't what I was anticipating as far as news but still believe Vik can takes this to a silver.
He's alot more active with this than his other companies.
Who knows, all small trades today, 151k was the biggest sell.
News was good, not bad, but it was not so great that people would be selling the news. So why is this going down today? Confused...
This pos is getting worst, I'm still hold but have no trust on it!
$HMLA $FOMC signing copack deal w manufacturer for FOMO CAN and GenBio for trial run 500 cases x 24 units for a market test looking to eventually go nationwide.
https://twitter.com/vikpgrover/status/1531710305666990081?s=21&t=Rf3NMEKAC6uc2SwxlHzalA
Good morning $HMLA nice piece of news out .
HERE WE GO!!!
$HMLA and $FOMC are connected?
8k out.
On June 1, 2022, we signed a co-pack agreement to create 500 cases of FOMO CAN with 24 units per case with a manufacturer in the Midwest. Costs include $50,000 for formulation of the product due to our minority investment GenBio Inc. (https://genbioinc.com/) and $20,000 for manufacturing due to the supplier. A trial run is contemplated with channel partners of the manufacturer, which makes and sells sodas and adult beverages in 32 states. The product is intended to provide anti-inflammatory and anti-blood pressure benefits and is anticipated to be a revolutionary health drink with no caffeine. The brand “FOMO” has been trademarked in the USA by our affiliate FOMO CORP. (OTC: FOMC).
$HMLA
Accumulation...90% buys today on best
volume in a month.Up 26%.
Could be a double tomorrow.
Its coming .128M Unrestricted great news
Getting ready to run
Cheapest i got was .0038 last week.
Our "Doubleday" is coming!
GLTA!
This is just getting started, should be multiple pennies.
$HMLA
Exactly not a bloated pig at all .....
GO $HMBL
HMLA SECURITY DETAILS
Share Structure
Market Cap Market Cap
618,248
05/27/2022
Authorized Shares
1,000,000,000
05/30/2022
Outstanding Shares
147,201,861
05/30/2022
Restricted
18,705,430
05/30/2022
Unrestricted
128,496,431
05/30/2022
Held at DTC
111,850,839
05/30/2022
Float
8,900,027
02/11/2015
Par Value
0.001
I am liking the Float here, 8 K filed last week .
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2022
HIMALAYA TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its Charter)
NEVADA 000-55282 26-0841675
(State or other jurisdiction
of incorporation)
(Commission
File No.)
(IRS Employer
Identification No.)
1 E Erie St, Ste 525 Unit #2420, Chicago, IL 60611
(Address of principal executive offices)
(630) 708-0750
(Registrant’s Telephone Number)
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading symbol(s) Name of each exchange on which registered
Common HMLA OTC Pink
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ?
FOMO CORP. is referred to herein as “FOMO”, “the Company”, “we”, or “us”.
Item 7.01 Regulation FD Disclosure.
We are hereby filing a presentation deck for our 19.9% minority investment GenBio, Inc. (https://genbioinc.com/).
Item 9.01. Exhibits
(a) Exhibits. The following exhibits are filed with this Current Report on Form 8-K:
Exhibit No. Description
10.1 GenBio, Inc. Presentation Deck – Spring 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Hey now!!! going up!!
The company needs to start putting out some PR's and get some attention on this, there hasn't been anything since getting current.
8K out this morning
Followers
|
178
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
19006
|
Created
|
03/21/11
|
Type
|
Free
|
Moderators |
Our business plan includes completing our social site Kanab.Club targeting health and wellness based in the cannabis market, generating revenues from advertising and subscriptions, incorporating social media site into the site, and marketing our planned 19.9% investment GenBio, Inc.’s health and wellness products targeting anti-inflammatory nutraceuticals to consumers. In the future, in partnership with GenBio, Inc., we plan to introduce a health and wellness energy and anti-inflammatory beverage product under the brand “FOMO” or other to drive growth. We are currently in discussions with co-pack and distribution companies, and GenBio, Inc. is formulating its extracts and obtaining laboratory certification for this planned consumer beverage.
On November 28, 2021 we issued 99,868 series B preferred shares of HMLA stock for 2,036,188 common shares of GENBIO Inc., representing 19.9% ownership. The GENBIO transaction is being accounted for as an investment on our balance sheet. We will not consolidate GENBIO’s financial statements.
On January 1, 2022, the Company signed a 19.9% stock purchase with The Agrarian Group LLC (“TAG”; , a provider of digital intelligence “AgtechDi” software designed from its granted patents to optimize the food supply chain by increasing food safety and profitability for growers who operate vertical farms, greenhouses, converted shipping containers, and other forms of controlled environment agriculture. Under the Investment Agreement, Himalaya is issuing TAG 99,686 Series B Preferred shares in exchange for 1,242,000 Class A Membership units of TAG. The transaction will be accounted for as an investment using a pre-money valuation for TAG of $10 million
KANAB CORP. is a development stage company targeting information services for the cannabis industry; we do not offer e-commerce services at this time and, given these matters, do not believe regulatory oversight or rules of law are a risk factor to our business.
We are in preliminary discussions with industry executives with contacts in the co-pack and distribution markets for canned and bottled beverages, though there can be assurances we will be successful in engaging any of these contacts for development of our pre-formulation pre-launch wellness beverage. Our planned beverage will not have any cannabis ingredients; it is derived from plum supplements and honey extracts sourced in South East Asia and Australia.
The Company has one wholly owned subsidiary, KANAB CORP. The Company has two investments, GenBio, Inc and The Agrarian Group, LLC. The Company owns 19.9% of GenBio and 19.9% of The Agrarian Group.
GenBio Inc is an early-stage biotechnology company that researches novel therapeutics from a variety of extracts. GenBio has, based on recent USA research, created an Investigational New Drug (IND) research program from novel natural compounds that are highly effective as anti-inflammatory agents.
GenBio has secured the services of a director who has been involved and directed international research into rare extracts since 2010. He initially worked alongside the pioneering investigational scientific teams who made a major medical breakthrough with the natural extract; subsequently he amassed further research worldwide with other scientific teams also investigating specific properties for the same new, disruptive molecular platforms for pain relief, anti-inflammation and age-related healthcare issues.
In 2014, he was the first individual to bring the rare extract to the USA for further phytochemical research. The subsequent and completely unexpected scientific findings, which have global implications for medicine, means that it is imperative to take the extract through an Investigational New Drug Program (IND), then divest or license at IND Phase 1 inflexion point.
GenBio is led by a very highly experienced international executive team in this rare category and aims to be the first company in the world to isolate and fractionate core molecules based on its remarkable scientific findings from the USA.
Agricultural Technologies for a Growing Planet
The Agrarian Group was started as an answer to a question - How will we feed the projected 9.1 Billion people that will reside on earth in 2050? To achieve this, we need to increase our already stressed agricultural production by 70%. How do we grow better?
No question of this gravity is that simple. As a species, we face the most complex and deadly problems we have ever encountered. Erratic weather events caused by climate change destroy crop yields each year. Pesticides have ruined our soil and water scarcity has become a national security issue. 70% of food cost is linked to fossil fuels, and prices are only expected to rise. The average food item travels 1500 miles to reach it's destination. However, despite everything we do, 40% of all food in the United States is thrown away post-harvest.
Reduce Water Usage
Reduce Need for Foreign Oil
Increase Food Safety
Create Local Food Systems
Increase Nutritional Value of Food
Benefit Local Communities
Economic Viability
Reduce Need for Pesticides
Increase Food Security
The Agrarian Group specializes in Controlled Environment Agriculture (CEA). By controlling as many variables as possible through technology, automation, energy efficiency, and sustainable design, The Agrarian Group is able to provide end to end solutions for customers looking to grow premium quality produce. Through The Agrarian Group's CEA integrated systems and services allow for significant increases in yield and quality, at very low resource intensities.
Less Water Used
Increase in Grow times
Output Ratio per sq. ft. Compared to Traditional Agriculture
Dependence on Soil Conditions
Reduction of Food Miles Possible
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |